| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10766928 | Biochemical and Biophysical Research Communications | 2007 | 7 Pages |
Abstract
In conclusion, EGCG is a low-affinity inhibitor of hERG sharing major electrophysiological features with pharmaceutical hERG antagonists.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Kamilla Kelemen, Claudia Kiesecker, Edgar Zitron, Alexander Bauer, Eberhard Scholz, Ramona Bloehs, Dierk Thomas, Johannes Greten, Andrew Remppis, Wolfgang Schoels, Hugo A. Katus, Christoph A. Karle,